# 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis

> **NCT00170872** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 135 (—)

## Conditions studied

- Osteoarthritis
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Lumiracoxib

## Key facts

- **NCT ID:** NCT00170872
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-07
- **Final completion:** —
- **Target enrollment:** 135 (—)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00170872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00170872, "6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00170872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*